"It was impressive to see that every dose of retatrutide resulted in clinically meaningful weight reduction for nearly all participants, and people with severe obesity on the highest dose lost on average 30% of their body weight over two years
GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes management and now some are also licensed for weight management
Studies on GLP-1 medications have found that they can all lead to weight loss (about 4.8 to 7.2kg (10.5 to 15.8 pounds) when using liraglutide and 15.3kg (33.7 pounds) when using semaglutide and making lifestyle changes
Some providers may prescribe phentermine for a few weeks to kickstart weight loss while a patient is slowly titrating up to their full dose of a GLP-1
In the present study, we found the augment of hepatocyte oxidation and premature aging, along with the decrease of plasm IGF-1 level in patients with liver fibrosis and CCl 4 -induced liver injury rat models
He can be reached at [email protected] and on LinkedIn, Instagram, YouTube and X.